These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6062155)

  • 1. [Evaluation of the effect of spinonolactone on myasthenia gravis using a double blind test].
    Yamada S; Ishii Y; Noguchi H; Ohara H
    Naika; 1967 Apr; 19(4):739-41. PubMed ID: 6062155
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of myasthenia with the aldosterone antagonist spironolactone].
    Lincke HO
    Munch Med Wochenschr; 1966 Feb; 108(5):270-4. PubMed ID: 6013740
    [No Abstract]   [Full Text] [Related]  

  • 3. Terbutaline in myasthenia gravis: a pilot study.
    Soliven B; Rezania K; Gundogdu B; Harding-Clay B; Oger J; Arnason BG
    J Neurol Sci; 2009 Feb; 277(1-2):150-4. PubMed ID: 18952242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and physiological studies of the effect of guanidine of patients with myasthenia gravis.
    Brown JC; Johns RJ
    Johns Hopkins Med J; 1969 Jan; 124(1):1-8. PubMed ID: 5762895
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of human myasthenia gravis with oral antisense suppression of acetylcholinesterase.
    Argov Z; McKee D; Agus S; Brawer S; Shlomowitz N; Yoseph OB; Soreq H; Sussman JD
    Neurology; 2007 Aug; 69(7):699-700. PubMed ID: 17698793
    [No Abstract]   [Full Text] [Related]  

  • 6. [Problems of long term administration of anti-cholinesterase preparations in myasthenia gravis].
    Ishikawa S; Mukuno K
    Nihon Rinsho; 1973 Feb; 31(2):359-63. PubMed ID: 4737119
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis.
    Tripathi M; Kaushik S; Dubey P
    J Postgrad Med; 2003; 49(4):311-4; discussion 314-5. PubMed ID: 14699228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of the efficacy of prednisone in the treatment of ocular myasthenia (EPITOME) trial.
    Benatar M; Sanders DB; Wolfe GI; McDermott MP; Tawil R
    Ann N Y Acad Sci; 2012 Dec; 1275():17-22. PubMed ID: 23278573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of intermittent noninvasive ventilation in anticholinesterase dose adjustment for myasthenic crisis.
    Mishra SK; Krishnappa S; Bhat RR; Badhe A
    Acta Anaesthesiol Taiwan; 2010 Mar; 48(1):53-4. PubMed ID: 20434116
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tactics in the management of pregnancy and labor in myasthenia gravis].
    Ivanov IP; Kolomenskaia EA; Iakovleva AN
    Akush Ginekol (Mosk); 1989 Aug; (8):33-6. PubMed ID: 2817277
    [No Abstract]   [Full Text] [Related]  

  • 11. Myasthenia gravis accompanied with hypokalemic periodic paralysis.
    Sawanyawisuth K; Tiamkao S; Pratipanawatr T
    J Med Assoc Thai; 2006 May; 89(5):727-9. PubMed ID: 16756062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of a respiratory form of myasthenia with venoglobulins combined with anticholinesterase agents and corticoids].
    Feillet F; Karcher C; Vidailhet M; Monin P
    Arch Fr Pediatr; 1993 Feb; 50(2):174-5. PubMed ID: 7688207
    [No Abstract]   [Full Text] [Related]  

  • 13. [Corticosteroid therapy combined with thymectomy in myasthenia gravis].
    Ito N; Hirayama K; Baba M; Yamaguchi Y; Kuroda N
    Rinsho Shinkeigaku; 1983 Apr; 23(4):338-46. PubMed ID: 6883880
    [No Abstract]   [Full Text] [Related]  

  • 14. [Case of long term administration of anti-cholinesterase preparations, with special reference to problems of the neuromuscular endplate].
    Segawa M
    Nihon Rinsho; 1973 Feb; 31(2):364-9. PubMed ID: 4737120
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of myasthenia gravis].
    Igata A
    Naika; 1970 Apr; 25(4):676-82. PubMed ID: 5423420
    [No Abstract]   [Full Text] [Related]  

  • 16. [Triaminopteridine in the therapy of myasthenia gravis].
    Mansoldo G; Battocchia A; De Candia O
    Minerva Med; 1968 Apr; 59(33):1936-9. PubMed ID: 5653968
    [No Abstract]   [Full Text] [Related]  

  • 17. Myasthenia gravis: case report and analysis.
    Hanson CJ
    J Am Osteopath Assoc; 1982 Feb; 81(6):378-81. PubMed ID: 7068459
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of aldactone-A on intracellular potassium in patients with myasthenia gravis.
    Oosterhuis HJ; van der Slooten EP
    J Neurol Sci; 1973 Aug; 19(4):453-60. PubMed ID: 4579659
    [No Abstract]   [Full Text] [Related]  

  • 19. The edrophonium test.
    Pascuzzi RM
    Semin Neurol; 2003 Mar; 23(1):83-8. PubMed ID: 12870109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapeutic trials in myasthenia gravis.
    Ozdemir C; Hatemi H; Yardimci B
    Panminerva Med; 1974; 16(5-6):190-4. PubMed ID: 4424580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.